Aragen's new cell line development and early manufacturing platform, CHOMax, can cut timelines to approximately 10 months.

MEDIPOST Inc., a biotechnology company developing allogeneic, umbilical cord blood-derived stem cell therapies for inflammation-driven degenerative diseases, today announced that its parent company, ...

MIT researchers are now turning the prolific Boltz series of models into a software company that promotes open science for AI-guided therapeutics.

Aston Sci. Inc., a clinical-stage biopharmaceutical company pioneering next-generation therapeutic cancer vaccines, announced ...

Secretary of Defense Pete Hegseth toured the factory of Long Beach rocket and satellite maker Rocket Lab, one of a new wave ...